This event will provide participants with a regional overview, as well as specific detail of the market access, pricing and reimbursement environment in key Latin American countries such as Brazil, Mexico, Argentina, Columbia, Venezuela, Chile, Panama, Costa Rica, among others. A thorough understanding will be achieved by hearing the perspectives of payers, government officials and key opinion leaders from academia, as well as learning from the case-study experiences from pharma industry veterans who have successfully overcome challenges to launch innovative medicines in this exciting region.
Why Attend? - Discover how payers are viewing risk-sharing agreements and what are their initiatives in the field.
- Learn how innovation is being rewarded and how market leaders are dealing with generic competition in the region.
- Understand the markets` affordability and willingness to reimburse high-cost drugs.
- Learn how to demonstrate product value to local HTA agencies, regulators and payers.
- Hear multi-stakeholder perspectives from: pharmaceutical industry, academia, HTA, policy-makers.
- Benchmark, network and co-operate with pharma & non-pharma decision makers.
- View the regional picture of market growth and market Access in Latin America.
- Get up to date on the development and establishment of health technology assessment in leading Latin American markets.
Who will benefit? Pharmaceutical companies: Vice-Presidents, Directors, Managers involved in: Market Access, Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Country Managers
Solution providers & consultants:CEOs, Business Development, Senior Consultants, Regional Heads
Plus:Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.
